All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Newron Pharmaceuticals S.p.A. revenue reports

Newron Pharmaceuticals S.p.A. financial reports, Newron Pharmaceuticals S.p.A. annual revenue in 2024. When does Newron Pharmaceuticals S.p.A. report revenue?
Add to widgets
Added to widgets

Newron Pharmaceuticals S.p.A. total revenue, net income and dynamics of changes in Swiss franc today

Newron Pharmaceuticals S.p.A. current income in Swiss franc. Net revenue Newron Pharmaceuticals S.p.A. is now 1 374 500 Fr. Information about net revenue is taken from open sources. The dynamics of Newron Pharmaceuticals S.p.A. net revenue has changed by 0 Fr over the last period. The financial report chart shows the values from 31/03/2019 to 31/12/2020. All information on Newron Pharmaceuticals S.p.A. total revenue on this chart is created in the form of yellow bars. The value of Newron Pharmaceuticals S.p.A. assets on the online chart is displayed in green bars.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
31/12/2020 1 345 892.29 Fr -42.801 % ↓ -5 138 282.85 Fr -
30/09/2020 1 345 892.29 Fr -42.801 % ↓ -5 138 282.85 Fr -
30/06/2020 1 228 389.87 Fr +12.41 % ↑ -5 142 199.60 Fr -
31/03/2020 1 228 389.87 Fr +12.41 % ↑ -5 142 199.60 Fr -
31/12/2019 2 352 985.94 Fr - -3 016 385.01 Fr -
30/09/2019 2 352 985.94 Fr - -3 016 385.01 Fr -
30/06/2019 1 092 772.49 Fr - -6 876 829.06 Fr -
31/03/2019 1 092 772.49 Fr - -6 876 829.06 Fr -
Show:
to

Newron Pharmaceuticals S.p.A. financial report charts

Dates of Newron Pharmaceuticals S.p.A. finance reports: 31/03/2019, 30/09/2020, 31/12/2020. The dates of the financial statements are determined by the accounting rules. The latest date of the financial report of Newron Pharmaceuticals S.p.A. is 31/12/2020. Gross profit Newron Pharmaceuticals S.p.A. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Newron Pharmaceuticals S.p.A. is 1 374 500 Fr

Newron Pharmaceuticals S.p.A. quarterly report dates

Total revenue Newron Pharmaceuticals S.p.A. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Newron Pharmaceuticals S.p.A. is 1 374 500 Fr Operating income Newron Pharmaceuticals S.p.A. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Newron Pharmaceuticals S.p.A. is -4 049 500 Fr Net income Newron Pharmaceuticals S.p.A. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Newron Pharmaceuticals S.p.A. is -5 247 500 Fr

Current assets Newron Pharmaceuticals S.p.A. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Newron Pharmaceuticals S.p.A. is 37 874 000 Fr Total assets Newron Pharmaceuticals S.p.A. refers to the total amount of assets owned by a person or entity. Total assets Newron Pharmaceuticals S.p.A. is 51 198 000 Fr Current cash Newron Pharmaceuticals S.p.A. - the sum of all of the cash a company has on the date of report. Current cash Newron Pharmaceuticals S.p.A. is 13 213 000 Fr

31/12/2020 30/09/2020 30/06/2020 31/03/2020 31/12/2019 30/09/2019 30/06/2019 31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
1 345 892.29 Fr 1 345 892.29 Fr 1 228 389.87 Fr 1 228 389.87 Fr 2 352 985.94 Fr 2 352 985.94 Fr 1 092 772.49 Fr 1 092 772.49 Fr
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
- - - - - - - -
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
1 345 892.29 Fr 1 345 892.29 Fr 1 228 389.87 Fr 1 228 389.87 Fr 2 352 985.94 Fr 2 352 985.94 Fr 1 092 772.49 Fr 1 092 772.49 Fr
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - - 2 352 985.94 Fr 2 352 985.94 Fr 1 092 772.49 Fr 1 092 772.49 Fr
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-3 965 217.04 Fr -3 965 217.04 Fr -4 879 777.53 Fr -4 879 777.53 Fr -3 162 283.84 Fr -3 162 283.84 Fr -7 069 728.86 Fr -7 069 728.86 Fr
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-5 138 282.85 Fr -5 138 282.85 Fr -5 142 199.60 Fr -5 142 199.60 Fr -3 016 385.01 Fr -3 016 385.01 Fr -6 876 829.06 Fr -6 876 829.06 Fr
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
3 535 354.02 Fr 3 535 354.02 Fr 3 736 576.92 Fr 3 736 576.92 Fr 3 568 156.78 Fr 3 568 156.78 Fr 4 970 352.31 Fr 4 970 352.31 Fr
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
5 311 109.33 Fr 5 311 109.33 Fr 6 108 167.40 Fr 6 108 167.40 Fr 5 515 269.78 Fr 5 515 269.78 Fr 8 162 501.36 Fr 8 162 501.36 Fr
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
37 085 721.73 Fr 37 085 721.73 Fr 42 656 315.57 Fr 42 656 315.57 Fr 58 698 333.29 Fr 58 698 333.29 Fr 58 178 385.08 Fr 58 178 385.08 Fr
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
50 132 406.96 Fr 50 132 406.96 Fr 56 630 290.72 Fr 56 630 290.72 Fr 59 033 215.18 Fr 59 033 215.18 Fr 58 593 560.30 Fr 58 593 560.30 Fr
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
12 937 995.49 Fr 12 937 995.49 Fr 21 402 086.39 Fr 21 402 086.39 Fr 21 593 027.82 Fr 21 593 027.82 Fr 11 986 225.90 Fr 11 986 225.90 Fr
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
- - - - 5 478 550.27 Fr 5 478 550.27 Fr 7 021 748.71 Fr 7 021 748.71 Fr
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - - - -
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
- - - - 23 001 098.47 Fr 23 001 098.47 Fr 17 480 443.16 Fr 17 480 443.16 Fr
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
- - - - 38.96 % 38.96 % 29.83 % 29.83 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
16 887 055.95 Fr 16 887 055.95 Fr 26 552 609.08 Fr 26 552 609.08 Fr 36 032 116.71 Fr 36 032 116.71 Fr 41 113 117.13 Fr 41 113 117.13 Fr
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
- - - - -3 662 648.31 Fr -3 662 648.31 Fr -7 211 221.36 Fr -7 211 221.36 Fr

Last revenue report of Newron Pharmaceuticals S.p.A. was 31/12/2020. According to last financial report total revenue in Newron Pharmaceuticals S.p.A. was 1 345 892.29 Swiss franc and changed by -42.801% since last year. Net income in Newron Pharmaceuticals S.p.A. was -5 138 282.85 Fr in last quartal, net income changes to 0%.

Newron Pharmaceuticals S.p.A. stocks data

Newron Pharmaceuticals S.p.A. financials